Rivaroxaban in acute venous thromboembolism: UK prescribing experience.
Victoria SpeedJignesh P PatelDerek CooperStephen MillerLara N RobertsRaj K PatelRoopen AryaPublished in: Research and practice in thrombosis and haemostasis (2021)
Rivaroxaban is an effective and safe single drug modality for the treatment of VTE in daily practice in the United Kingdom. Data to determine the optimal anticoagulation therapy for women of childbearing age are needed.
Keyphrases
- venous thromboembolism
- direct oral anticoagulants
- primary care
- liver failure
- healthcare
- drug induced
- polycystic ovary syndrome
- cross sectional
- physical activity
- electronic health record
- respiratory failure
- atrial fibrillation
- emergency department
- big data
- metabolic syndrome
- type diabetes
- quality improvement
- adipose tissue
- aortic dissection
- data analysis
- insulin resistance
- artificial intelligence
- acute respiratory distress syndrome